Lenz drops as BofA downgrades on a slower VIZZ launch
[Republican Politics and Wall Street] Douglas Rissing Shares of Lenz Therapeutics (LENZ [https://seekingalpha.com/symbol/LENZ]) slipped for the third consecutive session on Thursday after Bank of America downgraded the eye drug developer to Neutral from Buy, citing a slower-than-expected rollout of its presbyopia therapy VIZZ. In …